Your browser doesn't support javascript.
loading
Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival.
Cabezón, M; Malinverni, R; Bargay, J; Xicoy, B; Marcé, S; Garrido, A; Tormo, M; Arenillas, L; Coll, R; Borras, J; Jiménez, M J; Hoyos, M; Valcárcel, D; Escoda, L; Vall-Llovera, F; Garcia, A; Font, L L; Rámila, E; Buschbeck, M; Zamora, L.
Afiliação
  • Cabezón M; Hematology Laboratory Service, ICO Badalona-Hospital Germans Trias I Pujol, Myeloid Neoplasms Group, Josep Carreras Leukemia Research Institute (IJC), Badalona, Spain.
  • Malinverni R; Departament de Medicina, Universitat Autònoma de Barcelona, Badalona, Spain.
  • Bargay J; Cancer and Leukemia Epigenetics and Biology Program, Josep Carreras Leukemia Research Institute (IJC), Campus ICO-GTP-UAB, Badalona, Spain.
  • Xicoy B; Hematology Service, Hospital Son Llàtzer, Palma de Mallorca, Spain.
  • Marcé S; Hematology Laboratory Service, ICO Badalona-Hospital Germans Trias I Pujol, Myeloid Neoplasms Group, Josep Carreras Leukemia Research Institute (IJC), Badalona, Spain.
  • Garrido A; Departament de Medicina, Universitat Autònoma de Barcelona, Badalona, Spain.
  • Tormo M; Hematology Laboratory Service, ICO Badalona-Hospital Germans Trias I Pujol, Myeloid Neoplasms Group, Josep Carreras Leukemia Research Institute (IJC), Badalona, Spain.
  • Arenillas L; Hematology Service, Hospital de Sant Pau, Barcelona, Spain.
  • Coll R; Hematology Service, Hospital Clínico de Valencia, Valencia, Spain.
  • Borras J; Hematology Service, Hospital del Mar, Barcelona, Spain.
  • Jiménez MJ; Hematology Service, ICO Girona - Hospital Josep Trueta, Girona, Spain.
  • Hoyos M; Hematology Service, Hospital Son Llàtzer, Palma de Mallorca, Spain.
  • Valcárcel D; Hematology Laboratory Service, ICO Badalona-Hospital Germans Trias I Pujol, Myeloid Neoplasms Group, Josep Carreras Leukemia Research Institute (IJC), Badalona, Spain.
  • Escoda L; Hematology Service, Hospital de Sant Pau, Barcelona, Spain.
  • Vall-Llovera F; Hematology Service, Hospital Vall D'Hebron, Barcelona, Spain.
  • Garcia A; Hematology Service, Hospital Joan XXIII, Tarragona, Spain.
  • Font LL; Hematology Service, Hospital Mútua de Terrassa, Terrassa, Spain.
  • Rámila E; Hematology Service, Hospital Arnau de Vilanova, Lleida, Spain.
  • Buschbeck M; Hematology Service, Hospital Verge de La Cinta, Tortosa, Spain.
  • Zamora L; Hematology Service, Hospital Parc Taulí, Sabadell, Spain.
Clin Epigenetics ; 13(1): 9, 2021 01 14.
Article em En | MEDLINE | ID: mdl-33446256
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azacitidina / Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Metilação de DNA / Antimetabólitos Antineoplásicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Clin Epigenetics Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azacitidina / Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Metilação de DNA / Antimetabólitos Antineoplásicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Clin Epigenetics Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha